SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-003376 to GP-Act III Acquisition Corp. (GPAT, GPATU, GPATW) (CIK 0001834526) (GPAT)

GP-Act III Acquisition Corp. (GPAT, GPATU, GPATW) (CIK 0001834526)
Date: March 28, 2024 · CIK: 0001834526 · Accession: 0000000000-24-003376

AI Filing Summary & Sentiment

Date
March 28, 2024
Author
Not clearly detected
Form
UPLOAD
Company
GP-Act III Acquisition Corp. (GPAT, GPATU, GPATW) (CIK 0001834526)

Letter

United States securities and exchange commission logo March 28, 2024 Antonio Bonchristiano Chief Executive Officer GP-Act III Acquisition Corp. 300 Park Avenue 2nd Floor New York, NY 10022 Re:GP-Act III Acquisition Corp. Amendment No. 1 to Draft Registration Statement on Form S-1 Submitted March 8, 2024 CIK No.: 0001834526 Dear Antonio Bonchristiano: We have reviewed your amended draft registration statement and have the following comments. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to this letter and your amended draft registration statement or filed registration statement, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our February 15, 2024 letter. Draft Registration Statement on Form S-1 Summary The Offering, page 16 1.We refer to your disclosures on page 21, and elsewhere in your prospectus, that non- managing HoldCo investors will, through Sponsor HoldCo, purchase private placement warrants in connection with the closing of this offering, and also that you will not issue more than 7,000,000 private placement warrants because the non-managing HoldCo investors will be purchasing the warrants in a way that will "proportionally reduce the number of private placement warrants that would otherwise be purchased by the co- sponsors through Sponsor HoldCo." Your disclosure also states on page 139 in footnote 3 that GP-Sponsor holds 50% of the interest in the voting power in Sponsor HoldCo, and

FirstName LastNameAntonio Bonchristiano Comapany NameGP-Act III Acquisition Corp. March 28, 2024 Page 2 FirstName LastName Antonio Bonchristiano GP-Act III Acquisition Corp. March 28, 2024 Page 2 that investment and voting decisions are made by 51% or more of the voting power held by the managing members of Sponsor HoldCo. Please revise your disclosures as appropriate to clarify what type of interests in Sponsor HoldCo the non-managing HoldCo investors will be purchasing, and how is it that the purchase of these interests will not provide them with any "right to control Sponsor HoldCo or vote or dispose of any securities held by Sponsor HoldCo," as you state in various parts of your prospectus. Please also file the agreement with respect to the purchase of these private placement warrants, or advise. Risk Factors If we are deemed to be an investment company . . ., page 49 2.We acknowledge your revised disclosures in response to prior comment 4. Please further revise your risk factor to disclose clearly that if you are found to be operating as an unregistered investment company, you may be required to change your operations or wind down your operations. Also include disclosure with respect to the consequences to investors if you are required to wind down your operations as a result of this status, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and any warrants, which would expire worthless. Transfers of Founder Shares and Private Placement Warrants, page 141 3.You state that no member of Sponsor HoldCo may transfer any portion of its membership interests in Sponsor HoldCo except in certain specified circumstances. Please revise to clarify whether these restrictions also apply to the non-managing HoldCo investors. Please contact William Demarest at 202-551-3432 or Kristina Marrone at 202-551-3429 if you have questions regarding comments on the financial statements and related matters. Please contact Ruairi Regan at 202-551-3269 or Dorrie Yale at 202-551-8776 with any other questions. Sincerely, Division of Corporation Finance Office of Real Estate & Construction cc: J. Mathias VonBernuth, Esq.

Show Raw Text
United States securities and exchange commission logo
March 28, 2024
Antonio Bonchristiano
Chief Executive Officer
GP-Act III Acquisition Corp.
300 Park Avenue 2nd Floor
New York, NY 10022
Re:GP-Act III Acquisition Corp.
Amendment No. 1 to Draft Registration Statement on Form S-1
Submitted March 8, 2024
CIK No.: 0001834526
Dear Antonio Bonchristiano:
            We have reviewed your amended draft registration statement and have the following
comments.
            Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe a comment applies to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
            After reviewing the information you provide in response to this letter and your amended
draft registration statement or filed registration statement, we may have additional
comments. Unless we note otherwise, any references to prior comments are to comments in our
February 15, 2024 letter.
Draft Registration Statement on Form S-1
Summary
The Offering, page 16
1.We refer to your disclosures on page 21, and elsewhere in your prospectus, that non-
managing HoldCo investors will, through Sponsor HoldCo, purchase private placement
warrants in connection with the closing of this offering, and also that you will not issue
more than 7,000,000 private placement warrants because the non-managing HoldCo
investors will be purchasing the warrants in a way that will "proportionally reduce the
number of private placement warrants that would otherwise be purchased by the co-
sponsors through Sponsor HoldCo." Your disclosure also states on page 139 in footnote 3
that GP-Sponsor holds 50% of the interest in the voting power in Sponsor HoldCo, and

 FirstName LastNameAntonio Bonchristiano
 Comapany NameGP-Act III Acquisition Corp.
 March 28, 2024 Page 2
 FirstName LastName
Antonio Bonchristiano
GP-Act III Acquisition Corp.
March 28, 2024
Page 2
that investment and voting decisions are made by 51% or more of the voting power held
by the managing members of Sponsor HoldCo. Please revise your disclosures as
appropriate to clarify what type of interests in Sponsor HoldCo the non-managing HoldCo
investors will be purchasing, and how is it that the purchase of these interests will not
provide them with any "right to control Sponsor HoldCo or vote or dispose of any
securities held by Sponsor HoldCo," as you state in various parts of your prospectus.
Please also file the agreement with respect to the purchase of these private placement
warrants, or advise.
Risk Factors
If we are deemed to be an investment company . . ., page 49
2.We acknowledge your revised disclosures in response to prior comment 4. Please further
revise your risk factor to disclose clearly that if you are found to be operating as an
unregistered investment company, you may be required to change your operations or wind
down your operations. Also include disclosure with respect to the consequences
to investors if you are required to wind down your operations as a result of this status,
such as the losses of the investment opportunity in a target company, any price
appreciation in the combined company, and any warrants, which would expire worthless.
Transfers of Founder Shares and Private Placement Warrants, page 141
3.You state that no member of Sponsor HoldCo may transfer any portion of its membership
interests in Sponsor HoldCo except in certain specified circumstances. Please revise to
clarify whether these restrictions also apply to the non-managing HoldCo investors.
            Please contact William Demarest at 202-551-3432 or Kristina Marrone at 202-551-3429
if you have questions regarding comments on the financial statements and related matters. Please
contact Ruairi Regan at 202-551-3269 or Dorrie Yale at 202-551-8776 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction
cc:       J. Mathias VonBernuth, Esq.